Aquaretic and hormonal effects of a vasopressin V2 receptor antagonist after acute and long-term treatment in rats

This publication has 20 references indexed in Scilit:

• 5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V₂Receptors
  Journal of Medicinal Chemistry, 1998
• Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect
  Endocrinology, 1995
• Effect of vasopressin V1 (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function
  Life Sciences, 1994
• Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin
  Brain Research, 1994
• Nouveaux concepts sur la régulation de la sécrétion d'aldostérone ; interactions endocrines, paracrines, autocrines et neurocrines.
  médecine/sciences, 1993
• Oxytocin and arginine vasopressin stimulate steroid secretion by the isolated perfused rat adrenal gland
  Neuropeptides, 1987
• Receptors to vasopressin and other hormones in the mammalian kidney
  Kidney International, 1987
• Chronic Blockade of Vasopressin Receptors in Rats
  Journal of Cardiovascular Pharmacology, 1986
• LIGAND: A versatile computerized approach for characterization of ligand-binding systems
  Analytical Biochemistry, 1980
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976